Neuland Laboratories Ltd. (NEULANDLAB): Neuland Laboratories Share Price rises 2.35% today on Rs 28,858.65 crore market cap
- September 25, 2026
- Posted by: Harsh Piplani
- Category: News
Neuland Laboratories Share Price moved higher today, with the stock at Rs 22,425, up 2.35% from the previous close of Rs 21,909.40. The company’s market capitalisation is Rs 28,858.65 crore, placing the move in a clearly large-value context for today’s market update. The day range ran from Rs 22,163.10 to Rs 22,667.80, while turnover stood at Rs 5.7 crore. The data confirms a same-day price rise, but it does not establish a company-specific catalyst. For readers tracking Neuland Laboratories Share Price Today, the key focus is how the move fits with valuation, industry comparison and the company’s financial profile. Univest is covering the stock because today’s rise comes alongside a premium valuation profile versus the broader Pharmaceuticals & Drugs benchmark.
The latest Neuland Laboratories Stock News is therefore more than a simple price update. It combines the day’s share price rise with fundamentals such as earnings, profitability and book value, which help explain why the stock remains in focus on Univest and across broader Indian stock market screens.
Neuland Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 22,425 |
| Previous Close | Rs 21,909.4 |
| Today's Move | Rs 515.6 (+2.35%) |
| Open | Rs 22,163.1 |
| High | Rs 22,667.8 |
| Low | Rs 22,163.1 |
| Turnover | Rs 5.7 crore |
| Market Capitalisation | Rs 28,858.65 crore |
| Market Cap Category | Large Cap |
Neuland Laboratories Ltd. (NEULANDLAB) rose to Rs 22,425 from the previous close of Rs 21,909.4, a move of Rs 515.6 or 2.35%. The stock opened at Rs 22,163.1, reached a high of Rs 22,667.8, recorded a low of Rs 22,163.1.
Neuland Laboratories Share Price Today shows a clear intraday gain of Rs 515.60, or 2.35%, from the previous close of Rs 21,909.40 to Rs 22,425. The stock opened at Rs 22,163.10, matched the day’s low at the open, and later touched a high of Rs 22,667.80 before settling near the upper part of the range. That leaves the session with a positive close versus the previous day and a turnover of Rs 5.7 crore. The move confirms a share price rise, but the supplied data does not establish a company-specific reason. For Neuland Laboratories Stock News today, the verified facts are the price gain, the intraday range and the market capitalisation of Rs 28,858.65 crore.
Neuland Laboratories Ltd. (NEULANDLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 28,858.65 crore |
| P/E Ratio | 56.47x |
| P/B Ratio | 13.91x |
| ROE | 21.43% |
| ROCE | 27.5% |
| EPS | Rs 387.98 |
| Book Value Per Share | Rs 1,575.41 |
| Dividend Yield | 0.16% |
Neuland Laboratories Ltd. (NEULANDLAB) fundamental metrics show P/E 56.47x, P/B 13.91x, ROE 21.43%, ROCE 27.5%. These figures provide context only and are not a buy or sell signal.
Neuland Laboratories Ltd. has a market capitalisation of Rs 28858.65 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 56.47x, P/B at 13.91x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 21.43% and ROCE of 27.5%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 387.98, book value per share of Rs 1575.41, dividend yield of 0.16%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.73x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 56.47x |
| Benchmark Median P/E | 32.73x |
| Benchmark Average P/E | 49.58x |
| Benchmark P/E Range | 3.48x to 757.76x |
| Company P/B Ratio | 13.91x |
| Benchmark Median P/B | 2.95x |
| Company ROE | 21.43% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 27.5% |
| Benchmark Median ROCE | 13.61% |
| Company Market Capitalisation | Rs 28,858.65 crore |
| Benchmark Median Market Cap | Rs 804.62 crore |
Neuland Laboratories Ltd. (NEULANDLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Neuland Laboratories Ltd. (NEULANDLAB) has a P/E ratio of 56.47x, which is above the benchmark median of 32.73x, a difference of +72.53%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Neuland Laboratories Ltd. (NEULANDLAB) has a ROE of 21.43%, which is above the benchmark median of 11.7%, a difference of +83.16%. Neuland Laboratories Ltd. (NEULANDLAB) has a ROCE of 27.5%, which is above the benchmark median of 13.61%, a difference of +102.06%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,47,475.97 | 36.76 | 5.14 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,54,763.56 | 87.25 | 14.45 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,89,423.19 | 86.07 | 20.91 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,16,658.07 | 26.08 | 4.37 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,11,484.47 | 33.65 | 3.23 | 11.83 | 16 |
Neuland Laboratories Ltd. (NEULANDLAB) has a P/E ratio of 56.47x compared with the displayed peer median of 36.76x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 21.43% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 27.5% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Neuland Laboratories Ltd. (NEULANDLAB) has a market capitalisation of Rs 28,858.65 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Neuland Laboratories
- Neuland Laboratories Share Price rose 2.35% today to Rs 22,425.
- Market capitalisation stands at Rs 28,858.65 crore.
- P/E is 56.47 and P/B is 13.91, both above the industry median.
- ROE is 21.43% and ROCE is 27.5%, both above the industry benchmark median.
- Turnover for the session was Rs 5.7 crore, with the stock closing near the upper part of the day range.
About Neuland Laboratories
Neuland Laboratories is part of the Pharmaceuticals & Drugs industry in the Healthcare sector. Based on the supplied company context, it is a pharmaceutical business that operates within a sector where earnings quality, capital efficiency and valuation multiples are closely watched. The stock’s financial profile suggests that profitability and earnings power are important parts of the story, with EPS at Rs 387.98, book value at Rs 1,575.41 and dividend yield at 0.16%. That combination gives investors a way to read the company beyond the day’s price move. For anyone following Neuland Laboratories Latest News or Neuland Laboratories Company News, the main company-level takeaway is that the stock is being viewed through a mix of price action, profitability and industry benchmarking on Univest.
Track Neuland Laboratories Share Price on Univest
Use Neuland Laboratories Ltd. (NEULANDLAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Univest lets users track Neuland Laboratories Share Price Live, along with market cap, fundamental ratios, shareholding pattern, 52-week levels and broader market insights. You can also review Neuland Laboratories Stock Performance, company fundamentals, sector context and the latest share price update in one place on Univest.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Neuland Laboratories Share Price rise today?
Ans. Neuland Laboratories Share Price rose 2.35% to Rs 22,425 today. The supplied data confirms the price event, but it does not establish a company-specific catalyst for the move. The previous close was Rs 21,909.4.
What is Neuland Laboratories Share Price today?
Ans. Neuland Laboratories Share Price today is Rs 22,425. It was up Rs 515.60 from the previous close of Rs 21,909.40, with the stock trading between Rs 22,163.10 and Rs 22,667.80.
What is Neuland Laboratories market capitalisation?
Ans. Neuland Laboratories market capitalisation is Rs 28,858.65 crore. That places the company well above the same-industry median and average in the supplied Healthcare benchmark set. The company operates in the Healthcare sector.
How does Neuland Laboratories compare with peers on valuation?
Ans. Neuland Laboratories trades at a P/E of 56.47 and P/B of 13.91. Both are above the same-industry median, and the P/B is higher than most listed peers in the supplied comparison set.
What does Neuland Laboratories Share Price tell investors today?
Ans. Neuland Laboratories Share Price today reflects a verified same-day rise with a high valuation profile and solid return ratios. Investors can read the move alongside market cap, EPS, book value and industry comparisons.
Is Neuland Laboratories expensive versus the industry?
Ans. On the supplied benchmark, Neuland Laboratories looks expensive on P/E and P/B relative to the industry median. That higher valuation is balanced by stronger ROE and ROCE than the benchmark averages.
Where can I track Neuland Laboratories Share Price Live?
Ans. You can track Neuland Laboratories Share Price Live on Univest, where the stock page brings together price updates, valuation ratios, market cap, shareholding pattern and sector context in one view.
